RotaTeq: A New Oral Rotavirus Vaccine
The FDA has recently approved RotaTeq (Merck), an oral live, human-bovine reassortant rotavirus vaccine, for use in infants to prevent rotavirus gastroenteritis, a frequent cause of severe diarrhea in infancy. ...
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: RotaTeq: A New Oral Rotavirus Vaccine
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1240
Article Code: 1240b
Date: July 31, 2006
Volume: 48
Pages: 61-62
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1240
Article Code: 1240b
Date: July 31, 2006
Volume: 48
Pages: 61-62
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)